Merck & Co is reportedly in talks to acquire biotech company Seagen Inc. in a nearly $40 billon deal that would add to the company's cancer drug portfolio.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

https://www.facebook.com/pages/Laser-Focus-World/126899915297

https://www.linkedin.com/showcase/laser-focus-world

https://twitter.com/LaserFocusWorld

https://youtube.com/laserfocusworld

About Us
Contact Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions